MediPharm Labs Corp.
MediPharm Labs Corp. (MEDIF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
medif · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
MediPharm Labs Corp.You MEDIF | $22M | N/A | — | -$0.02 |
 Avicanna Inc. AVCNF | $10M | N/A | — | -$0.02 |
 INDVR Brands Inc. CAAOF | $0M | N/A | — | -$0.06 |
 Choom Holdings Inc. CHOOF | $0M | N/A | — | -$0.07 |
 Charlotte's Web Holdings, Inc. CWBHF | $67M | N/A | — | -$0.19 |
 Molecule Holdings Inc. EVRRF | $1M | N/A | — | -$0.05 |
 Global Pharmatech, Inc. GBLP | $29M | N/A | — | -$0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for MediPharm Labs Corp. (MEDIF) measures how much investors pay for each dollar of the company's trailing earnings. MEDIF's current PE ratio of N/A is calculated by dividing its stock price of $0.05 by its TTM earnings per share of -$0.02.
Frequently asked questions
MEDIF pe ratio · 6 questionsMEDIF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.05 and TTM EPS of -$0.02. Data sourced from Financial Modeling Prep via MEDIF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · MediPharm Labs Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09